Led by Simon Vandekar, PhD, a group of biostatisticians earned the honor for tools that help brain researchers tell strong, trustworthy findings from weak ones. Vanderbilt Health teams took two of 15 total NIH prizes.

The FROSTBITE-2 trial used the 1.1-millimeter cryoprobe which, unlike the larger probes, is small enough to remove the biopsy specimen through the working channel without having to remove the scope, which increases safety.

A new platform allows visualization of drug-tumor interactions in human solid tumors, providing a tool for measuring drug delivery and signaling.

The Tennessee Department of Health, through the Opioid Abatement Council Community Grant program, recently awarded $1.2M to The Naloxone Project, a nonprofit dedicated to patient-centric care for individuals with opioid use disorder.

Vanderbilt-Ingram Cancer Center is “pushing the envelope” with new technologies like histotripsy and new programs like robotic liver surgery and robotic pancreas surgery, serving patients not only from Tennessee, but also parts of Kentucky, Alabama and Georgia.  

Jean-Paul Marie, MD, PhD, a physician from France who has spent over two decades honing the selective laryngeal reinnervation, presented at the second annual Robert H. Ossoff Lecture and was a guest in the operating room for Vanderbilt Health’s seventh such surgery.

The new artificial intelligence tool aims to spare Vanderbilt Health patients and clinicians the back-and-forth that can delay answers to patients' electronic health care questions.